- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Nicole Rosendale Says Data Collection Is Step 1 for Value-Based Care in the Neurology Space for LGBTQ+ Individuals
Nicole Rosendale, MD, assistant professor of neurology at the University of California San Francisco, neurologist/neurohospitalist, talks about how data on the LGBTQ+ community in the neurology space is needed in order to provide effective value-based health care.
More data is needed in order to provide true value-based care to LGBTQ+ community memebers, says Nicole Rosendale, MD, assistant professor of neurology at the University of California San Francisco, neurologist/neurohospitalist.
Transcript
How can value-based health care methods help the LGBTQ+ community in the neurology space?
This is such an important question, and I think the idea of value-based care has a lot of momentum behind it. The challenge is that value-based care requires data. It requires measurement of outcomes; reporting back continual iteration of the process to improve the quality of care. The challenge is with that measurement piece, and so not very many folks collect sexual orientation or gender identity in their data routinely. So, we don't have that first part; we don't have the data to go into the process, to talk about outcomes, to talk about how we can do better for service for the community and access and outcomes within care. So, I think that really working on that first step is going to hopefully drive us towards be able to actually provide value-based care for LGBTQ individuals.
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
The study found significant disparities in the exposure to contaminants. Communities with higher percentages of Hispanic and Black residents were not only more likely to have unregulated chemicals in their drinking water, but they were also more frequently located near pollution sources.
Read More
